Non-coding RNAs: the new central dogma of cancer biology
The central dogma of molecular biology states that the functions of RNA revolve around
protein translation. Until the last decade, most researches were geared towards …
protein translation. Until the last decade, most researches were geared towards …
Metabolic reprogramming in glioma
M Strickland, EA Stoll - Frontiers in cell and developmental biology, 2017 - frontiersin.org
Many cancers have long been thought to primarily metabolize glucose for energy production—
a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the …
a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the …
[HTML][HTML] AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo
AMPK is a metabolic sensor that helps maintain cellular energy homeostasis. Despite
evidence linking AMPK with tumor suppressor functions, the role of AMPK in tumorigenesis …
evidence linking AMPK with tumor suppressor functions, the role of AMPK in tumorigenesis …
The microcosmos of cancer
A Lujambio, SW Lowe - Nature, 2012 - nature.com
The discovery of microRNAs (miRNAs) almost two decades ago established a new
paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have …
paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have …
Ribosomal protein S6: a potential therapeutic target against cancer?
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
Recent advances in the molecular understanding of glioblastoma
FE Bleeker, RJ Molenaar, S Leenstra - Journal of neuro-oncology, 2012 - Springer
Glioblastoma is the most common and most aggressive primary brain tumor. Despite
maximum treatment, patients only have a median survival time of 15 months, because of the …
maximum treatment, patients only have a median survival time of 15 months, because of the …
Selective release of microRNA species from normal and malignant mammary epithelial cells
L Pigati, SCS Yaddanapudi, R Iyengar, DJ Kim… - PloS one, 2010 - journals.plos.org
MicroRNAs (miRNAs) in body fluids are candidate diagnostics for a variety of conditions and
diseases, including breast cancer. One premise for using extracellular miRNAs to diagnose …
diseases, including breast cancer. One premise for using extracellular miRNAs to diagnose …
The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator
The AMP-activated protein kinase (AMPK) is a central regulator of cellular metabolism and
energy homeostasis in mammalian tissues. Pertinent to cancer biology is the fact that AMPK …
energy homeostasis in mammalian tissues. Pertinent to cancer biology is the fact that AMPK …
Targeting adaptive glioblastoma: an overview of proliferation and invasion
Glioblastoma is one of the most devastating cancers, in which tumor cell infiltration into
surrounding normal brain tissue confounds clinical management. This review describes …
surrounding normal brain tissue confounds clinical management. This review describes …